×

Biotech and Pharmaceuticals Medicine

  • Nightmare at the Pittsburgh VA

    The "Street Signs" crew reports on an outbreak of Legionnaires' disease that has resulted in patient deaths at the VA hospital in Pittsburgh.

  • NFL former players reach settlement

    The NFL will pay $765 million to settle lawsuits brought by 4,500 former players who claim the league knew and hid the dangers of concussions from them, reports CNBC's Mary Thompson.

  • New Jersey Governor Chris Christie speaks at Sayreville Borough Hall on July 8, 2013 in Sayreville, New Jersey.

    New Jersey Gov. Chris Christie agreed Friday to give chronically ill children easier access to medical marijuana, but he was unwilling to go as far as state lawmakers wanted.

  • President Obama discusses the Affordable Care Act in June in San Jose, Calif.

    Another delay in Obamacare gives critics of the health-reform law more ammunition and will take money of out chronically ill people's pockets.

  • Personalized medicine: the next big thing?

    Alex Gunz, fund manager at Heptagon Capital, talks to CNBC about the profound changes that will occur as medicine becomes proactive.

  • A growing epidemic of overdoses of prescription painkillers is leading to record numbers of deaths, especially among women, the Centers for Disease Control and Prevention says.

  • GlaxoSmithKline Shanghai headquarters

    China is barring a GlaxoSmithKline executive from leaving the country amid a widening $490 bribery scandal ensaring the drug giant.

  • China is preventing a GlaxoSmithKline executive from leaving the country as police accuse the British drugmaker of bribing officials and doctors, the drugmaker says.

  • China is using "concerted" probes of foreign baby formula, pharmaceutical and packaging companies to bolster domestic firms, according to observers.

  • In a recent study, fish oil proved dangerous for men who have high levels of the compounds because it raises the risk of prostate cancer.

  • Legal medical marijuana grown in a greenhouse.

    Marijuana, though still considered controversial, continues to prove itself in as a successful prescription for neurological diseases that appear in children.

  • A group of researchers recently developed a telescopic contact lens that enables wearers to magnify their sight by almost three times.

  • Dr. Tony Coles, Chairman & CEO of Onyx

    Amgen's low-ball offer to Onyx Pharmaceuticals has set off speculation of a potential bidding war that could leave another company walking away with Onyx.

  • Mounting medical bills are likely to force many people to file for bankruptcy, according to new data from NerdWallet. And even those with insurance are buckling under unpaid bills.

  • Obesity a Disease

    The American Medical Association says obesity should be classified as a disease. CNBC's Bertha Coombs reports AMA's Patrice Harris says the hope is for doctors to be more proactive in treating obese patients.

  • Obamacare's Med School Dilemma

    Discussing the big problems Obamacare creates for hospitals, doctors, and even medical students, with Dr. Beth Haynes M.D. of Benjamin Rush Society, Brian Blank, UNC-Chapel Hill Medical Student.

  • U.S. Supreme Court Building

    Can someone else patent your genes? The Supreme Court is scheduled to rule some time this month on that question. NBCNews.com reports.

  • The Worst Allergy Season Ever

    Allergy season has been getting longer every year for 15 years, with Dr. Michael Foggs of American College of Allergy, Asthma and Immunology; and Stephen Brozak, WBB Securities, discusses the big money in the allergy business.

  • Mayo Clinic's CEO on $5 Billion Expansion

    John Noseworthy, Mayo Clinic president and CEO, discusses what his company is doing to create more jobs, the best opportunities internationally for growth and Obamacare.

  • Rise In Melanoma Treatments

    CNBC's Jackie DeAngelis reports on drug companies making headlines out of the American Society of Clinical Onocology conference. David Risinger of Morgan Stanley discusses the rise in melanoma treatments shown at this year's event.